Monitor for any stockholder proposals or director nominations that may be submitted by the July 27 deadline, particularly if an activist investor or dissident group emerges. The absence of a 2025 annual meeting may increase scrutiny of governance and board composition, but no concrete catalyst is present yet.
Price Chart
Executive Summary
Polaryx Therapeutics filed an 8-K setting the date for its 2026 Annual Meeting of Stockholders as September 10, 2026, to be held virtually. The record date is July 27, 2026. Because no annual meeting was held in 2025, the filing also establishes an accelerated July 27, 2026 deadline for stockholder proposals and director nominations under Rule 14a-8. This is a routine administrative filing with no financial or operational impact.
Key Facts
- 2026 Annual Meeting scheduled for September 10, 2026, to be held virtually
- Record date for voting is July 27, 2026
- Stockholder proposals and director nominations must be received by July 27, 2026 deadline
- No annual meeting was held by the company during 2025
Financial Impact
No financial impact — filing sets meeting date and proposal deadlines only
Risk Factors
- Stockholder proposals or director nominations could surface ahead of the July 27 deadline, potentially leading to a contested meeting or governance changes
- No specific business or financial catalysts identified in this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-078912 |
| Document: 0001213900-26-078912-index-headers.html | 0001213900-26-078912 |
| Document: 0001213900-26-078912-index.html | 0001213900-26-078912 |
| Document: 0001213900-26-078912.txt | 0001213900-26-078912 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 17, 2026 14w ago | 8-K | $2.28 $2.01 | ▼ −11.84% | ▼ −16.53% | $1.88 (−17.54%) |
May 28, 2026 21w ago | 8-K | $3.27 $1.87 | ▼ −42.81% | ▼ −44.00% | $1.88 (−42.51%) |
May 28, 2026 21w ago | Press Release | $3.05 $2.07 | ▼ −32.13% | ▼ −33.87% | $1.88 (−38.36%) |
Apr 21, 2026 27w ago | Press Release | $5.27 $2.31 | ▼ −56.17% | ▼ −63.07% | $1.88 (−64.33%) |
Mar 17, 2026 32w ago | Press Release | $5.63 $2.28 | ▼ −59.50% | ▼ −69.36% | $1.88 (−66.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers